Close
ACHEMA MIDDLE EAST 2026

More Monitoring Required of Institutional Review Boards

The Government Accountability Office has issued an analysis suggesting that the FDA should increase its oversight of institutional review boards (IRBs) to better protect...

Germany Rolls First CAR-T Push For Muscle Inflammation Cure

One of the university hospitals in Germany was the first in the world to effectively treat a patient with a severe case of muscular...

Hong Kong Gives $500mn Funding For Chinese Drug Development

The Hong Kong government announced plans to add $500 million to the Chinese Medicine Development Fund beginning with this fiscal year during a budget...

Booming Performance By The Life Sciences Biz In Wales

Office for Life Sciences - OLS numbers, which were released on December 1, 2022, and cover data till the end of the financial year...

Efficacy Shown On Cystic Fibrosis Patients In 4-Year Study

The combination of modulator therapies tezacaftor (TEZ) and ivacaftor (IVA) for cystic fibrosis (CF) has shown long-term safety as well as clinical benefit in...

Animal Testing Could See An End With An Artificial Model

Uppsala University researchers have created an artificial blood-brain barrier model that can be used to assess the efficacy of anti-body-based medicines while reducing animal...

Duchenne Muscular Dystrophy-Cancer Genetic Link Discovered

Scientists from the University of Portsmouth have settled on a novel genetic link between Duchenne muscular dystrophy and cancer. Duchenne muscular dystrophy, which happens...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...